Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
Janke F, Stritzke F, Dvornikovich K, Franke H, Angeles AK, Riediger AL, Ogrodnik S, Gerhardt S, Regnery S, Schröter P, Bauer L, Weusthof K, Görtz M, Harrabi S, Herfarth K, Neelsen C, Paech D, Schlemmer HP, Abdollahi A, Adeberg S, Debus J, Sültmann H, Held T.
Janke F, et al.
Int J Cancer. 2024 Aug 30. doi: 10.1002/ijc.35152. Online ahead of print.
Int J Cancer. 2024.
PMID: 39212345